Last Posted: Jan 03, 2020
- A multistage sequencing strategy pinpoints novel candidate alleles for Emery-Dreifuss muscular dystrophy and supports gene misregulation as its pathomechanism.
Meinke Peter et al. EBioMedicine 2019 Dec - Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy.
Signorelli Mirko et al. Journal of cachexia, sarcopenia and muscle 2019 Dec - Emery-Dreifuss Muscular Dystrophy.
Heller Scott A et al. Muscle & nerve 2019 Dec - Detection of collagens by multispectral optoacoustic tomography as an imaging biomarker for Duchenne muscular dystrophy.
Regensburger Adrian P et al. Nature medicine 2019 Dec 25(12) 1905-1915 - Muscular dystrophies
E Mercuri et al, The Lancet, November 2019 - Grants for Rare Disease Research
F Sankar, JAMA< November 19, 2019 - Genetic analysis of 62 Chinese families with Duchenne muscular dystrophy and strategies of prenatal diagnosis in a single center.
Zhang Jingjing et al. BMC medical genetics 2019 Nov 20(1) 180 - Gene-Editing Advance Puts More Gene-Based Cures Within Reach
F Collins, NIH Director Blog, November 5, 2019 - Clinical utility of RNA sequencing to resolve unusual GNE myopathy with a novel promoter deletion.
Chakravorty Samya et al. Muscle & nerve 2019 60(1) 98-103 - Vision of the Future of Medical Science
Francis Collins, Time, October 25, 2019
.png)
No hay comentarios:
Publicar un comentario